Published in Scand J Immunol on January 01, 1980
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med (1986) 5.23
Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med (1981) 5.00
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Antigen presenting cells in situ: their identification and involvement in immunopathology. Clin Exp Immunol (1983) 1.75
Resident and "inflammatory" dendritic cells in human skin. J Invest Dermatol (2008) 1.72
In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol (1982) 1.71
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
The involvement of interdigitating (antigen-presenting) cells in the pathogenesis of rheumatoid arthritis. Clin Exp Immunol (1983) 1.56
Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol (1984) 1.29
Treponemal infection specifically enhances node T-cell regulation of macrophage activity. Infect Immun (1986) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon. Clin Exp Immunol (1988) 0.95
Langerhans cells present tick antigens to lymph node cells from tick-sensitized guinea-pigs. Immunology (1985) 0.86
Ia antigens are expressed on ATPase-positive dendritic cells in chicken epidermis. J Anat (1994) 0.84
Purified human oral mucosal Langerhans cells function as accessory cells in vitro. Clin Exp Immunol (1993) 0.82
Modulation of CD4 antigen expression on human gingival Langerhans cells by gamma interferon. Clin Exp Immunol (1987) 0.81
Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol (2009) 0.81
Herpes simplex virus type 1 pathogenicity in footpad and ear skin of mice depends on Langerhans cell density, mouse genetics, and virus strain. J Virol (1987) 0.79
Evaluation of ATPase-positive Langerhans' cells in skin lesions of lupus erythematosus and experimentally induced inflammations. Arch Dermatol Res (1989) 0.79
Distribution of Langerhans cells in skin lesions of MRL/l mice. Arch Dermatol Res (1988) 0.78
Effects on rat T-helper cell proliferation by syngeneic epidermal cells exposed to IFN-gamma in vivo. Immunology (1989) 0.78
Reconstructed human epidermis: absence of Langerhans cells and failure to stimulate allogeneic lymphocytes in vitro. Clin Exp Immunol (1988) 0.75
Immunoelectron microscopic analysis of Ia antigen expression in rat skin during limb allograft rejection. Am J Pathol (1990) 0.75
Induction of sensitization and tolerance in contact sensitivity with haptenated epidermal cells in the guinea-pig. Immunology (1987) 0.75
Epidermis and lymphocyte interactions during a tuberculin skin reaction. I. Increased ETAF/IL-1 like activity, expression of tissue antigens and mixed skin lymphocyte reactivity. Arch Dermatol Res (1988) 0.75
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Langerhans cells as primary target cells for HIV infection. Lancet (1987) 2.97
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72
HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol (2012) 2.41
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51
The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50
Sporadic hypomelanosis of Ito with focal hypertrichosis in a 16-month-old girl. Dermatology (1996) 1.45
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol (1998) 1.43
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region. J Exp Med (1977) 1.38
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
The human major histocompatibility system. Transplant Rev (1974) 1.25
Eosinophils and atopic dermatitis. Allergy (2004) 1.25
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22
A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22
HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19
Cell specific and common antigens on human granulocytes and lymphocytes demonstrated with cytotoxic hetero-antibodies. Vox Sang (1967) 1.19
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol (1999) 1.17
Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17
Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. Transplant Proc (1979) 1.17
Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16
Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15
HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14
Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11
Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy (2000) 1.11
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11
Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. J Immunol Methods (1977) 1.10
Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol (1981) 1.10
T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1989) 1.09
Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venereol (1980) 1.09
Human epidermal Langerhans cells induce cellular immune response to trichophytin in dermatophytosis. Br J Dermatol (1983) 1.07
T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol (1994) 1.07
The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik (1975) 1.07
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 1.06
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.06
Human afferent lymph from normal skin contains an increased number of mainly memory / effector CD4(+) T cells expressing activation, adhesion and co-stimulatory molecules. Eur J Immunol (2000) 1.06
HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum (1983) 1.05
HLA-D region products are expressed in endothelial cells. Tissue Antigens (1980) 1.03
Polymorphism of the HL-A system. Transplant Proc (1971) 1.03
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics (1996) 1.02
In vitro sensitization of human T lymphocytes to hapten (TNP)-conjugated and non-treated autologous cells is restricted by self-HLA-D. Scand J Immunol (1979) 1.02
Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol (2011) 1.02
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet (1998) 1.01
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells. J Virol Methods (1989) 1.01
Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet (1997) 1.01
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). Hum Mol Genet (1998) 1.01
Cutaneous nocardiosis caused by Nocardia brasiliensis after an insect bite. Dermatology (1999) 1.00
Activation of human suppressor cells in mixed lymphocyte cultures. Scand J Immunol (1977) 1.00
Further evidence of a third HL-A locus. Tissue Antigens (1973) 1.00
C3 polymorphism: genetic linkage relations. Clin Genet (1974) 1.00
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet (2001) 1.00
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol (1989) 0.99
On the orientation of the HL-A region and the PGM3 locus in the chromosome. Tissue Antigens (1972) 0.99
HLA-D-restricted antigen activation of sensitized T lymphocytes: studies on the ability of HLA-D/DR-expressing B lymphocytes to substitute for macrophages in antigen activation. Scand J Immunol (1979) 0.99
Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun (2009) 0.98
Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatis. Scand J Immunol (1983) 0.98
Beta-2-microglobulin is part of the HL-A molecule in the lymphocyte membrane. Nature (1974) 0.98